Breakthrough Sleeping Sickness Drug Approved for DNDi
March 4, 2026Recommendation based on Phase II/III study demonstrating up to 96 per cent success rates at 18 months across both early and advanced stages of T.b. gambiense, the most common form of sleeping sicknessThe therapy, given as a single dose of...
read more
South Sudan: Mass causality in Abiemnhom Town
March 4, 2026Early on Sunday morning, 1 March, large-scale violent clashes occurred in Abiemnhom town, in the northwest of Ruweng Administrative Area, significantly impacting people.MSF supports the Ministry of Health Hospital in Abyei town which has so far received 80 patients with...
read more
